- Home
- LXFR vs CADL Comparison
LXFR vs CADL Comparison
Compare LXFR & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXFR
- CADL
- Stock Information
- Founded
- LXFR 1898
- CADL 1999
- Country
- LXFR United States
- CADL United States
- Employees
- LXFR N/A
- CADL N/A
- Industry
- LXFR Major Chemicals
- CADL Biotechnology: Pharmaceutical Preparations
- Sector
- LXFR Industrials
- CADL Health Care
- Exchange
- LXFR Nasdaq
- CADL Nasdaq
- Market Cap
- LXFR 380.9M
- CADL 306.4M
- IPO Year
- LXFR 2012
- CADL 2021
- Fundamental
- Price
- LXFR $11.73
- CADL $5.31
- Analyst Decision
- LXFR
- CADL Strong Buy
- Analyst Count
- LXFR 0
- CADL 4
- Target Price
- LXFR N/A
- CADL $21.00
- AVG Volume (30 Days)
- LXFR 125.0K
- CADL 1.1M
- Earning Date
- LXFR 04-29-2025
- CADL 03-13-2025
- Dividend Yield
- LXFR 4.46%
- CADL N/A
- EPS Growth
- LXFR N/A
- CADL N/A
- EPS
- LXFR 0.68
- CADL N/A
- Revenue
- LXFR $391,900,000.00
- CADL N/A
- Revenue This Year
- LXFR $2.26
- CADL N/A
- Revenue Next Year
- LXFR $5.85
- CADL N/A
- P/E Ratio
- LXFR $17.25
- CADL N/A
- Revenue Growth
- LXFR N/A
- CADL N/A
- 52 Week Low
- LXFR $9.26
- CADL $1.56
- 52 Week High
- LXFR $15.64
- CADL $14.60
- Technical
- Relative Strength Index (RSI)
- LXFR 39.86
- CADL 28.78
- Support Level
- LXFR $11.43
- CADL $7.85
- Resistance Level
- LXFR $11.94
- CADL $5.90
- Average True Range (ATR)
- LXFR 0.30
- CADL 0.63
- MACD
- LXFR 0.05
- CADL -0.35
- Stochastic Oscillator
- LXFR 37.04
- CADL 4.80
About LXFR Luxfer Holdings PLC
Luxfer Holdings PLC is a manufacturer industrial company innovating niche applications in materials engineering. It focuses on value creation by using its broad array of technical know-how and proprietary technologies to help create a safe, clean, and energy-efficient world. Luxfer's high-performance materials, components, and high-pressure gas containment devices are used in defense, first response and healthcare, transportation, and general industrial applications. It focuses on product lines related to magnesium alloys, zirconium chemicals, and carbon composites. Its segments are Elektron, Gas Cylinders, and Graphic Arts. It generates the majority of its revenue from Elektron and as well as Gas Cylinders.
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.